Prognostic factors and Doxorubicin involved in malignant progression of meningioma.

Sci Rep · 2023 · PMC10079659 · PMID 37024523

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

essentially significantno p-value reported

However, the distinction of the OS and progression-free survival (PFS) was essentially significant, with poorer outcome found in the malignant progression patients (Fig. 1 G,H).

also in 54 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.